Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock - $0.001 par value
-
Shares outstanding
-
10.6M
-
Number of holders
-
17
-
Total 13F shares, excl. options
-
4.71M
-
Shares change
-
+7.19K
-
Total reported value, excl. options
-
$6.91M
-
Value change
-
+$947
-
Number of buys
-
3
-
Number of sells
-
-9
-
Price
-
$1.47
Significant Holders of NEPHROS INC - Common Stock - $0.001 par value (NEPH) as of Q4 2024
19 filings reported holding NEPH - NEPHROS INC - Common Stock - $0.001 par value as of Q4 2024.
NEPHROS INC - Common Stock - $0.001 par value (NEPH) has 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.71M shares
of 10.6M outstanding shares and own 44.32% of the company stock.
Largest 10 shareholders include WEXFORD CAPITAL LP (3.6M shares), Topline Capital Management, LLC (420K shares), VANGUARD GROUP INC (202K shares), BARD ASSOCIATES INC (155K shares), GEODE CAPITAL MANAGEMENT, LLC (84.9K shares), HighTower Advisors, LLC (55.7K shares), ELKHORN PARTNERS LIMITED PARTNERSHIP (41.4K shares), UBS Group AG (40.2K shares), BLAIR WILLIAM & CO/IL (36.2K shares), and SUSQUEHANNA INTERNATIONAL GROUP, LLP (23.8K shares).
This table shows the top 17 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.